LncRNA GUSBP5-AS promotes EPC migration and angiogenesis and deep vein thrombosis resolution by regulating FGF2 and MMP2/9 through the miR-223-3p/FOXO1/Akt pathway

Li-Li Sun,Feng-Rui Lei,Xu-Dong Jiang,Xiao-Long Du,Lun Xiao,Wen-Dong Li,Xiao-Qiang Li
DOI: https://doi.org/10.18632/aging.102904
2020-03-10
Aging
Abstract:Long non-coding RNAs (lncRNAs) play an essential role in multitudinous physiological and pathological processes, including vascular disease. We previously showed that lncRNA <i>GUSBP5-AS</i> (enst00000511042) is upregulated in endothelial progenitor cells (EPCs) of deep veni thrombosis (DVT) patients. Here, we investigate the role and mechanism of <i>GUSBP5-AS</i> in EPCs and DVT. Using the DVT model, we found that <i>GUSBP5-AS</i> significantly reduced the thrombus size and weight and enhanced the homing ability of EPC to DVT sites to promote resolution and recanalization of thrombus. <i>GUSBP5-AS</i> promoted cell cycle progression, proliferation, migration and invasion in EPCs, enhanced EPC angiogenesis <i>in vitro</i> and <i>in vivo</i>, and inhibited apoptosis. Strikingly, this study showed that <i>GUSBP5-AS</i> was unbalanced and modulated Forkhead Box Protein O1 (FOXO1) in EPCs in patients with DVT by interacting with <i>miR-223-3p</i>. Mechanistically, <i>GUSBP5-AS</i> functions as a sponge of <i>miR-223-3p</i>, which targets FOXO1. Both <i>GUSBP5-AS</i> knockdown and <i>miR-223-3p</i> overexpression remarkably inhibited angiogenesis, migration and invasion in EPCs. Additionally, our data suggested that <i>GUSBP-AS</i> activated the Akt pathway and enhanced fibroblast growth factor 2 (FGF2), matrix metalloproteinase-2/9 (MMP2/9) and F-actin expression. Taken together, this study indicates that <i>GUSBP5-AS</i> modulates angiogenesis, proliferation and homing ability of EPCs via regulating FGF2 and MMP2/9 expression through the <i>miR-223-3p</i>/FOXO1/Akt pathway, which may provide a new direction for the development of DVT therapeutics.
What problem does this paper attempt to address?